Yoshie Akimoto
Tokyo, 1030027, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chinese prescription Kangen-karyu attenuates neuronal damage and improves cognitive function in global cerebral ischemia/reperfusion by regulating ROS-mediated MAPK activation.
Journal: Frontiers in pharmacology
Published: April 23, 2026
Impdh2 deficiency suppresses osteoclastogenesis through mitochondrial oxidative phosphorylation and alleviates ovariectomy-induced osteoporosis.
Journal: Biochemical and biophysical research communications
Published: June 17, 2024
Morusin inhibits breast cancer-induced osteolysis by decreasing phosphatidylinositol 3-kinase (PI3K)-mTOR signalling.
Journal: Chemico-biological interactions
Published: January 13, 2024
A p38 MAP kinase inhibitor suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss through the inhibition of bone turnover.
Journal: Biochemical pharmacology
Published: January 11, 2024
Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 22, 2023
Pan-Cancer Profiling of Intron Retention and Its Clinical Significance in Diagnosis and Prognosis.
Journal: Cancers
Published: October 14, 2023
Development, Validation and Characterization of a Novel Portable Closed Fracture Device.
Journal: In vivo (Athens, Greece)
Published: August 09, 2023
Therapeutic Potential of Two Derivative Prescriptions of Rokumijiogan, Hachimijiogan and Bakumijiogan against Renal Damage in Nephrectomized Rats.
Journal: Medicines (Basel, Switzerland)
Published: January 12, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026